Global Opioids Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Opioids Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Opioids Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Oxycodone
  • 1.2.3 Hydromorphone
  • 1.2.4 Codeine
  • 1.2.5 Fentanyl
  • 1.2.6 Other
• 1.3 Market by Application
  • 1.3.1 Global Opioids Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Pain Relief
  • 1.3.3 Anesthesia
  • 1.3.4 Cough Suppression
  • 1.3.5 Diarrhea Suppression
  • 1.3.6 Deaddiction
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Opioids Sales Estimates and Forecasts 2017-2028
• 2.2 Global Opioids Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Opioids Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Opioids Sales by Region
  • 2.4.1 Global Opioids Sales by Region (2017-2022)
  • 2.4.2 Global Sales Opioids by Region (2023-2028)
• 2.5 Global Opioids Revenue by Region
  • 2.5.1 Global Opioids Revenue by Region (2017-2022)
  • 2.5.2 Global Opioids Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Opioids Sales by Manufacturers
  • 3.1.1 Global Top Opioids Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Opioids Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Opioids in 2021
• 3.2 Global Opioids Revenue by Manufacturers
  • 3.2.1 Global Opioids Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Opioids Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Opioids Revenue in 2021
• 3.3 Global Opioids Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Opioids Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Opioids Sales by Type
  • 4.1.1 Global Opioids Historical Sales by Type (2017-2022)
  • 4.1.2 Global Opioids Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Opioids Sales Market Share by Type (2017-2028)
• 4.2 Global Opioids Revenue by Type
  • 4.2.1 Global Opioids Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Opioids Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Opioids Revenue Market Share by Type (2017-2028)
• 4.3 Global Opioids Price by Type
  • 4.3.1 Global Opioids Price by Type (2017-2022)
  • 4.3.2 Global Opioids Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Opioids Sales by Application
  • 5.1.1 Global Opioids Historical Sales by Application (2017-2022)
  • 5.1.2 Global Opioids Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Opioids Sales Market Share by Application (2017-2028)
• 5.2 Global Opioids Revenue by Application
  • 5.2.1 Global Opioids Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Opioids Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Opioids Revenue Market Share by Application (2017-2028)
• 5.3 Global Opioids Price by Application
  • 5.3.1 Global Opioids Price by Application (2017-2022)
  • 5.3.2 Global Opioids Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Opioids Market Size by Type
  • 6.1.1 North America Opioids Sales by Type (2017-2028)
  • 6.1.2 North America Opioids Revenue by Type (2017-2028)
• 6.2 North America Opioids Market Size by Application
  • 6.2.1 North America Opioids Sales by Application (2017-2028)
  • 6.2.2 North America Opioids Revenue by Application (2017-2028)
• 6.3 North America Opioids Market Size by Country
  • 6.3.1 North America Opioids Sales by Country (2017-2028)
  • 6.3.2 North America Opioids Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Opioids Market Size by Type
  • 7.1.1 Europe Opioids Sales by Type (2017-2028)
  • 7.1.2 Europe Opioids Revenue by Type (2017-2028)
• 7.2 Europe Opioids Market Size by Application
  • 7.2.1 Europe Opioids Sales by Application (2017-2028)
  • 7.2.2 Europe Opioids Revenue by Application (2017-2028)
• 7.3 Europe Opioids Market Size by Country
  • 7.3.1 Europe Opioids Sales by Country (2017-2028)
  • 7.3.2 Europe Opioids Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Opioids Market Size by Type
  • 8.1.1 Asia Pacific Opioids Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Opioids Revenue by Type (2017-2028)
• 8.2 Asia Pacific Opioids Market Size by Application
  • 8.2.1 Asia Pacific Opioids Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Opioids Revenue by Application (2017-2028)
• 8.3 Asia Pacific Opioids Market Size by Region
  • 8.3.1 Asia Pacific Opioids Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Opioids Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Opioids Market Size by Type
  • 9.1.1 Latin America Opioids Sales by Type (2017-2028)
  • 9.1.2 Latin America Opioids Revenue by Type (2017-2028)
• 9.2 Latin America Opioids Market Size by Application
  • 9.2.1 Latin America Opioids Sales by Application (2017-2028)
  • 9.2.2 Latin America Opioids Revenue by Application (2017-2028)
• 9.3 Latin America Opioids Market Size by Country
  • 9.3.1 Latin America Opioids Sales by Country (2017-2028)
  • 9.3.2 Latin America Opioids Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Opioids Market Size by Type
  • 10.1.1 Middle East and Africa Opioids Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Opioids Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Opioids Market Size by Application
  • 10.2.1 Middle East and Africa Opioids Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Opioids Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Opioids Market Size by Country
  • 10.3.1 Middle East and Africa Opioids Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Opioids Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Teva
  • 11.1.1 Teva Corporation Information
  • 11.1.2 Teva Overview
  • 11.1.3 Teva Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Teva Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Teva Recent Developments
• 11.2 Purdue Pharma
  • 11.2.1 Purdue Pharma Corporation Information
  • 11.2.2 Purdue Pharma Overview
  • 11.2.3 Purdue Pharma Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Purdue Pharma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Purdue Pharma Recent Developments
• 11.3 Mallinckrodt
  • 11.3.1 Mallinckrodt Corporation Information
  • 11.3.2 Mallinckrodt Overview
  • 11.3.3 Mallinckrodt Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Mallinckrodt Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Mallinckrodt Recent Developments
• 11.4 Amneal Pharma
  • 11.4.1 Amneal Pharma Corporation Information
  • 11.4.2 Amneal Pharma Overview
  • 11.4.3 Amneal Pharma Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Amneal Pharma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Amneal Pharma Recent Developments
• 11.5 Collegium
  • 11.5.1 Collegium Corporation Information
  • 11.5.2 Collegium Overview
  • 11.5.3 Collegium Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Collegium Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Collegium Recent Developments
• 11.6 J&J
  • 11.6.1 J&J Corporation Information
  • 11.6.2 J&J Overview
  • 11.6.3 J&J Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 J&J Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 J&J Recent Developments
• 11.7 Endo
  • 11.7.1 Endo Corporation Information
  • 11.7.2 Endo Overview
  • 11.7.3 Endo Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Endo Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Endo Recent Developments
• 11.8 Pfizer
  • 11.8.1 Pfizer Corporation Information
  • 11.8.2 Pfizer Overview
  • 11.8.3 Pfizer Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Pfizer Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Pfizer Recent Developments
• 11.9 INSYS
  • 11.9.1 INSYS Corporation Information
  • 11.9.2 INSYS Overview
  • 11.9.3 INSYS Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 INSYS Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 INSYS Recent Developments
• 11.10 Mylan
  • 11.10.1 Mylan Corporation Information
  • 11.10.2 Mylan Overview
  • 11.10.3 Mylan Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Mylan Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Mylan Recent Developments
• 11.11 Hikma
  • 11.11.1 Hikma Corporation Information
  • 11.11.2 Hikma Overview
  • 11.11.3 Hikma Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 Hikma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Hikma Recent Developments
• 11.12 Egalet
  • 11.12.1 Egalet Corporation Information
  • 11.12.2 Egalet Overview
  • 11.12.3 Egalet Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Egalet Opioids Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Egalet Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Opioids Industry Chain Analysis
• 12.2 Opioids Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Opioids Production Mode & Process
• 12.4 Opioids Sales and Marketing
  • 12.4.1 Opioids Sales Channels
  • 12.4.2 Opioids Distributors
• 12.5 Opioids Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Opioids Industry Trends
• 13.2 Opioids Market Drivers
• 13.3 Opioids Market Challenges
• 13.4 Opioids Market Restraints

14 Key Findings in The Global Opioids Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Opioids Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Oxycodone
• Table 3. Major Manufacturers of Hydromorphone
• Table 4. Major Manufacturers of Codeine
• Table 5. Major Manufacturers of Fentanyl
• Table 6. Major Manufacturers of Other
• Table 7. Global Opioids Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 8. Global Opioids Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 9. Global Opioids Sales by Region (2017-2022) & (MT)
• Table 10. Global Opioids Sales Market Share by Region (2017-2022)
• Table 11. Global Opioids Sales by Region (2023-2028) & (MT)
• Table 12. Global Opioids Sales Market Share by Region (2023-2028)
• Table 13. Global Opioids Revenue by Region (2017-2022) & (US$ Million)
• Table 14. Global Opioids Revenue Market Share by Region (2017-2022)
• Table 15. Global Opioids Revenue by Region (2023-2028) & (US$ Million)
• Table 16. Global Opioids Revenue Market Share by Region (2023-2028)
• Table 17. Global Opioids Sales by Manufacturers (2017-2022) & (MT)
• Table 18. Global Opioids Sales Share by Manufacturers (2017-2022)
• Table 19. Global Opioids Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 20. Global Opioids Revenue Share by Manufacturers (2017-2022)
• Table 21. Opioids Price by Manufacturers (2017-2022) &(USD/Kg)
• Table 22. Global Opioids Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 23. Global Opioids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids as of 2021)
• Table 24. Opioids Manufacturing Base Distribution and Headquarters
• Table 25. Manufacturers Opioids Product Offered
• Table 26. Date of Manufacturers Enter into Opioids Market
• Table 27. Mergers & Acquisitions, Expansion Plans
• Table 28. Global Opioids Sales by Type (2017-2022) & (MT)
• Table 29. Global Opioids Sales by Type (2023-2028) & (MT)
• Table 30. Global Opioids Sales Share by Type (2017-2022)
• Table 31. Global Opioids Sales Share by Type (2023-2028)
• Table 32. Global Opioids Revenue by Type (2017-2022) & (US$ Million)
• Table 33. Global Opioids Revenue by Type (2023-2028) & (US$ Million)
• Table 34. Global Opioids Revenue Share by Type (2017-2022)
• Table 35. Global Opioids Revenue Share by Type (2023-2028)
• Table 36. Opioids Price by Type (2017-2022) & (USD/Kg)
• Table 37. Global Opioids Price Forecast by Type (2023-2028) & (USD/Kg)
• Table 38. Global Opioids Sales by Application (2017-2022) & (MT)
• Table 39. Global Opioids Sales by Application (2023-2028) & (MT)
• Table 40. Global Opioids Sales Share by Application (2017-2022)
• Table 41. Global Opioids Sales Share by Application (2023-2028)
• Table 42. Global Opioids Revenue by Application (2017-2022) & (US$ Million)
• Table 43. Global Opioids Revenue by Application (2023-2028) & (US$ Million)
• Table 44. Global Opioids Revenue Share by Application (2017-2022)
• Table 45. Global Opioids Revenue Share by Application (2023-2028)
• Table 46. Opioids Price by Application (2017-2022) & (USD/Kg)
• Table 47. Global Opioids Price Forecast by Application (2023-2028) & (USD/Kg)
• Table 48. North America Opioids Sales by Type (2017-2022) & (MT)
• Table 49. North America Opioids Sales by Type (2023-2028) & (MT)
• Table 50. North America Opioids Revenue by Type (2017-2022) & (US$ Million)
• Table 51. North America Opioids Revenue by Type (2023-2028) & (US$ Million)
• Table 52. North America Opioids Sales by Application (2017-2022) & (MT)
• Table 53. North America Opioids Sales by Application (2023-2028) & (MT)
• Table 54. North America Opioids Revenue by Application (2017-2022) & (US$ Million)
• Table 55. North America Opioids Revenue by Application (2023-2028) & (US$ Million)
• Table 56. North America Opioids Sales by Country (2017-2022) & (MT)
• Table 57. North America Opioids Sales by Country (2023-2028) & (MT)
• Table 58. North America Opioids Revenue by Country (2017-2022) & (US$ Million)
• Table 59. North America Opioids Revenue by Country (2023-2028) & (US$ Million)
• Table 60. Europe Opioids Sales by Type (2017-2022) & (MT)
• Table 61. Europe Opioids Sales by Type (2023-2028) & (MT)
• Table 62. Europe Opioids Revenue by Type (2017-2022) & (US$ Million)
• Table 63. Europe Opioids Revenue by Type (2023-2028) & (US$ Million)
• Table 64. Europe Opioids Sales by Application (2017-2022) & (MT)
• Table 65. Europe Opioids Sales by Application (2023-2028) & (MT)
• Table 66. Europe Opioids Revenue by Application (2017-2022) & (US$ Million)
• Table 67. Europe Opioids Revenue by Application (2023-2028) & (US$ Million)
• Table 68. Europe Opioids Sales by Country (2017-2022) & (MT)
• Table 69. Europe Opioids Sales by Country (2023-2028) & (MT)
• Table 70. Europe Opioids Revenue by Country (2017-2022) & (US$ Million)
• Table 71. Europe Opioids Revenue by Country (2023-2028) & (US$ Million)
• Table 72. Asia Pacific Opioids Sales by Type (2017-2022) & (MT)
• Table 73. Asia Pacific Opioids Sales by Type (2023-2028) & (MT)
• Table 74. Asia Pacific Opioids Revenue by Type (2017-2022) & (US$ Million)
• Table 75. Asia Pacific Opioids Revenue by Type (2023-2028) & (US$ Million)
• Table 76. Asia Pacific Opioids Sales by Application (2017-2022) & (MT)
• Table 77. Asia Pacific Opioids Sales by Application (2023-2028) & (MT)
• Table 78. Asia Pacific Opioids Revenue by Application (2017-2022) & (US$ Million)
• Table 79. Asia Pacific Opioids Revenue by Application (2023-2028) & (US$ Million)
• Table 80. Asia Pacific Opioids Sales by Region (2017-2022) & (MT)
• Table 81. Asia Pacific Opioids Sales by Region (2023-2028) & (MT)
• Table 82. Asia Pacific Opioids Revenue by Region (2017-2022) & (US$ Million)
• Table 83. Asia Pacific Opioids Revenue by Region (2023-2028) & (US$ Million)
• Table 84. Latin America Opioids Sales by Type (2017-2022) & (MT)
• Table 85. Latin America Opioids Sales by Type (2023-2028) & (MT)
• Table 86. Latin America Opioids Revenue by Type (2017-2022) & (US$ Million)
• Table 87. Latin America Opioids Revenue by Type (2023-2028) & (US$ Million)
• Table 88. Latin America Opioids Sales by Application (2017-2022) & (MT)
• Table 89. Latin America Opioids Sales by Application (2023-2028) & (MT)
• Table 90. Latin America Opioids Revenue by Application (2017-2022) & (US$ Million)
• Table 91. Latin America Opioids Revenue by Application (2023-2028) & (US$ Million)
• Table 92. Latin America Opioids Sales by Country (2017-2022) & (MT)
• Table 93. Latin America Opioids Sales by Country (2023-2028) & (MT)
• Table 94. Latin America Opioids Revenue by Country (2017-2022) & (US$ Million)
• Table 95. Latin America Opioids Revenue by Country (2023-2028) & (US$ Million)
• Table 96. Middle East and Africa Opioids Sales by Type (2017-2022) & (MT)
• Table 97. Middle East and Africa Opioids Sales by Type (2023-2028) & (MT)
• Table 98. Middle East and Africa Opioids Revenue by Type (2017-2022) & (US$ Million)
• Table 99. Middle East and Africa Opioids Revenue by Type (2023-2028) & (US$ Million)
• Table 100. Middle East and Africa Opioids Sales by Application (2017-2022) & (MT)
• Table 101. Middle East and Africa Opioids Sales by Application (2023-2028) & (MT)
• Table 102. Middle East and Africa Opioids Revenue by Application (2017-2022) & (US$ Million)
• Table 103. Middle East and Africa Opioids Revenue by Application (2023-2028) & (US$ Million)
• Table 104. Middle East and Africa Opioids Sales by Country (2017-2022) & (MT)
• Table 105. Middle East and Africa Opioids Sales by Country (2023-2028) & (MT)
• Table 106. Middle East and Africa Opioids Revenue by Country (2017-2022) & (US$ Million)
• Table 107. Middle East and Africa Opioids Revenue by Country (2023-2028) & (US$ Million)
• Table 108. Teva Corporation Information
• Table 109. Teva Description and Major Businesses
• Table 110. Teva Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 111. Teva Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 112. Teva Recent Developments
• Table 113. Purdue Pharma Corporation Information
• Table 114. Purdue Pharma Description and Major Businesses
• Table 115. Purdue Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 116. Purdue Pharma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 117. Purdue Pharma Recent Developments
• Table 118. Mallinckrodt Corporation Information
• Table 119. Mallinckrodt Description and Major Businesses
• Table 120. Mallinckrodt Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 121. Mallinckrodt Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 122. Mallinckrodt Recent Developments
• Table 123. Amneal Pharma Corporation Information
• Table 124. Amneal Pharma Description and Major Businesses
• Table 125. Amneal Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 126. Amneal Pharma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 127. Amneal Pharma Recent Developments
• Table 128. Collegium Corporation Information
• Table 129. Collegium Description and Major Businesses
• Table 130. Collegium Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 131. Collegium Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 132. Collegium Recent Developments
• Table 133. J&J Corporation Information
• Table 134. J&J Description and Major Businesses
• Table 135. J&J Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 136. J&J Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 137. J&J Recent Developments
• Table 138. Endo Corporation Information
• Table 139. Endo Description and Major Businesses
• Table 140. Endo Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 141. Endo Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 142. Endo Recent Developments
• Table 143. Pfizer Corporation Information
• Table 144. Pfizer Description and Major Businesses
• Table 145. Pfizer Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 146. Pfizer Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 147. Pfizer Recent Developments
• Table 148. INSYS Corporation Information
• Table 149. INSYS Description and Major Businesses
• Table 150. INSYS Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 151. INSYS Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 152. INSYS Recent Developments
• Table 153. Mylan Corporation Information
• Table 154. Mylan Description and Major Businesses
• Table 155. Mylan Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 156. Mylan Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 157. Mylan Recent Developments
• Table 158. Hikma Corporation Information
• Table 159. Hikma Description and Major Businesses
• Table 160. Hikma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 161. Hikma Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 162. Hikma Recent Developments
• Table 163. Egalet Corporation Information
• Table 164. Egalet Description and Major Businesses
• Table 165. Egalet Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 166. Egalet Opioids Product Model Numbers, Pictures, Descriptions and Specifications
• Table 167. Egalet Recent Developments
• Table 168. Key Raw Materials Lists
• Table 169. Raw Materials Key Suppliers Lists
• Table 170. Opioids Distributors List
• Table 171. Opioids Customers List
• Table 172. Opioids Market Trends
• Table 173. Opioids Market Drivers
• Table 174. Opioids Market Challenges
• Table 175. Opioids Market Restraints
• Table 176. Research Programs/Design for This Report
• Table 177. Key Data Information from Secondary Sources
• Table 178. Key Data Information from Primary Sources

List of Figures

• Figure 1. Opioids Product Picture
• Figure 3. Global Opioids Market Share by Type in 2021 & 2028
• Figure 3. Oxycodone Product Picture
• Figure 4. Hydromorphone Product Picture
• Figure 5. Codeine Product Picture
• Figure 6. Fentanyl Product Picture
• Figure 7. Other Product Picture
• Figure 8. Global Opioids Market Share by Application in 2021 & 2028
• Figure 9. Pain Relief
• Figure 10. Anesthesia
• Figure 11. Cough Suppression
• Figure 12. Diarrhea Suppression
• Figure 13. Deaddiction
• Figure 14. Others
• Figure 15. Opioids Report Years Considered
• Figure 16. Global Opioids Sales 2017-2028 (MT)
• Figure 17. Global Opioids Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 18. Global Opioids Revenue 2017-2028 (US$ Million)
• Figure 19. Global Opioids Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 20. Global Opioids Sales Market Share by Region (2017-2022)
• Figure 21. Global Opioids Sales Market Share by Region (2023-2028)
• Figure 22. North America Opioids Sales YoY (2017-2028) & (MT)
• Figure 23. North America Opioids Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Europe Opioids Sales YoY (2017-2028) & (MT)
• Figure 25. Europe Opioids Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. Asia-Pacific Opioids Sales YoY (2017-2028) & (MT)
• Figure 27. Asia-Pacific Opioids Revenue YoY (2017-2028) & (US$ Million)
• Figure 28. Latin America Opioids Sales YoY (2017-2028) & (MT)
• Figure 29. Latin America Opioids Revenue YoY (2017-2028) & (US$ Million)
• Figure 30. Middle East & Africa Opioids Sales YoY (2017-2028) & (MT)
• Figure 31. Middle East & Africa Opioids Revenue YoY (2017-2028) & (US$ Million)
• Figure 32. The Opioids Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 33. The Top 5 and 10 Largest Manufacturers of Opioids in the World: Market Share by Opioids Revenue in 2021
• Figure 34. Global Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 35. Global Opioids Sales Market Share by Type (2017-2028)
• Figure 36. Global Opioids Revenue Market Share by Type (2017-2028)
• Figure 37. Global Opioids Sales Market Share by Application (2017-2028)
• Figure 38. Global Opioids Revenue Market Share by Application (2017-2028)
• Figure 39. North America Opioids Sales Market Share by Type (2017-2028)
• Figure 40. North America Opioids Revenue Market Share by Type (2017-2028)
• Figure 41. North America Opioids Sales Market Share by Application (2017-2028)
• Figure 42. North America Opioids Revenue Market Share by Application (2017-2028)
• Figure 43. North America Opioids Sales Share by Country (2017-2028)
• Figure 44. North America Opioids Revenue Share by Country (2017-2028)
• Figure 45. U.S. Opioids Revenue (2017-2028) & (US$ Million)
• Figure 46. Canada Opioids Revenue (2017-2028) & (US$ Million)
• Figure 47. Europe Opioids Sales Market Share by Type (2017-2028)
• Figure 48. Europe Opioids Revenue Market Share by Type (2017-2028)
• Figure 49. Europe Opioids Sales Market Share by Application (2017-2028)
• Figure 50. Europe Opioids Revenue Market Share by Application (2017-2028)
• Figure 51. Europe Opioids Sales Share by Country (2017-2028)
• Figure 52. Europe Opioids Revenue Share by Country (2017-2028)
• Figure 53. Germany Opioids Revenue (2017-2028) & (US$ Million)
• Figure 54. France Opioids Revenue (2017-2028) & (US$ Million)
• Figure 55. U.K. Opioids Revenue (2017-2028) & (US$ Million)
• Figure 56. Italy Opioids Revenue (2017-2028) & (US$ Million)
• Figure 57. Russia Opioids Revenue (2017-2028) & (US$ Million)
• Figure 58. Asia Pacific Opioids Sales Market Share by Type (2017-2028)
• Figure 59. Asia Pacific Opioids Revenue Market Share by Type (2017-2028)
• Figure 60. Asia Pacific Opioids Sales Market Share by Application (2017-2028)
• Figure 61. Asia Pacific Opioids Revenue Market Share by Application (2017-2028)
• Figure 62. Asia Pacific Opioids Sales Share by Region (2017-2028)
• Figure 63. Asia Pacific Opioids Revenue Share by Region (2017-2028)
• Figure 64. China Opioids Revenue (2017-2028) & (US$ Million)
• Figure 65. Japan Opioids Revenue (2017-2028) & (US$ Million)
• Figure 66. South Korea Opioids Revenue (2017-2028) & (US$ Million)
• Figure 67. India Opioids Revenue (2017-2028) & (US$ Million)
• Figure 68. Australia Opioids Revenue (2017-2028) & (US$ Million)
• Figure 69. Taiwan Opioids Revenue (2017-2028) & (US$ Million)
• Figure 70. Indonesia Opioids Revenue (2017-2028) & (US$ Million)
• Figure 71. Thailand Opioids Revenue (2017-2028) & (US$ Million)
• Figure 72. Malaysia Opioids Revenue (2017-2028) & (US$ Million)
• Figure 73. Philippines Opioids Revenue (2017-2028) & (US$ Million)
• Figure 74. Latin America Opioids Sales Market Share by Type (2017-2028)
• Figure 75. Latin America Opioids Revenue Market Share by Type (2017-2028)
• Figure 76. Latin America Opioids Sales Market Share by Application (2017-2028)
• Figure 77. Latin America Opioids Revenue Market Share by Application (2017-2028)
• Figure 78. Latin America Opioids Sales Share by Country (2017-2028)
• Figure 79. Latin America Opioids Revenue Share by Country (2017-2028)
• Figure 80. Mexico Opioids Revenue (2017-2028) & (US$ Million)
• Figure 81. Brazil Opioids Revenue (2017-2028) & (US$ Million)
• Figure 82. Argentina Opioids Revenue (2017-2028) & (US$ Million)
• Figure 83. Middle East and Africa Opioids Sales Market Share by Type (2017-2028)
• Figure 84. Middle East and Africa Opioids Revenue Market Share by Type (2017-2028)
• Figure 85. Middle East and Africa Opioids Sales Market Share by Application (2017-2028)
• Figure 86. Middle East and Africa Opioids Revenue Market Share by Application (2017-2028)
• Figure 87. Middle East and Africa Opioids Sales Share by Country (2017-2028)
• Figure 88. Middle East and Africa Opioids Revenue Share by Country (2017-2028)
• Figure 89. Turkey Opioids Revenue (2017-2028) & (US$ Million)
• Figure 90. Saudi Arabia Opioids Revenue (2017-2028) & (US$ Million)
• Figure 91. U.A.E Opioids Revenue (2017-2028) & (US$ Million)
• Figure 92. Opioids Value Chain
• Figure 93. Opioids Production Process
• Figure 94. Channels of Distribution
• Figure 95. Distributors Profiles
• Figure 96. Bottom-up and Top-down Approaches for This Report
• Figure 97. Data Triangulation
• Figure 98. Key Executives Interviewed